Article

Cinnamon for diabetes mellitus

School of Nursing & Midwifery, University of South Australia, Adelaide, South Australia. .
Cochrane database of systematic reviews (Online) (Impact Factor: 5.94). 01/2012; 9(9):CD007170. DOI: 10.1002/14651858.CD007170.pub2
Source: PubMed

ABSTRACT Diabetes mellitus is a chronic metabolic disorder that is associated with an increased risk of cardiovascular disease, retinopathy, nephropathy, neuropathy, sexual dysfunction and periodontal disease. Improvements in glycaemic control may help to reduce the risk of these complications. Several animal studies show that cinnamon may be effective in improving glycaemic control. While these effects have been explored in humans also, findings from these studies have not yet been systematically reviewed.
To evaluate the effects of cinnamon in patients with diabetes mellitus.
Pertinent randomised controlled trials were identified through AARP Ageline, AMED, AMI, BioMed Central gateway, CAM on PubMed, CINAHL, Dissertations Abstracts International, EMBASE, Health Source Nursing/Academic edition, International Pharmaceutical Abstracts, MEDLINE, Natural medicines comprehensive database, The Cochrane Library and TRIP database. Clinical trial registers and the reference lists of included trials were searched also (all up to January 2012). Content experts and manufacturers of cinnamon extracts were also contacted.
All randomised controlled trials comparing the effects of orally administered monopreparations of cinnamon (Cinnamomum spp.) to placebo, active medication or no treatment in persons with either type 1 or type 2 diabetes mellitus.
Two review authors independently selected trials, assessed risk of bias and trial quality, and extracted data. We contacted study authors for missing information.
Ten prospective, parallel-group design, randomised controlled trials, involving a total of 577 participants with type 1 and type 2 diabetes mellitus, were identified. Risk of bias was high or unclear in all but two trials, which were assessed as having moderate risk of bias. Risk of bias in some domains was high in 50% of trials. Oral monopreparations of cinnamon (predominantly Cinnamomum cassia) were administered at a mean dose of 2 g daily, for a period ranging from 4 to 16 weeks. The effect of cinnamon on fasting blood glucose level was inconclusive. No statistically significant difference in glycosylated haemoglobin A1c (HbA1c), serum insulin or postprandial glucose was found between cinnamon and control groups. There were insufficient data to pool results for insulin sensitivity. No trials reported health-related quality of life, morbidity, mortality or costs. Adverse reactions to oral cinnamon were infrequent and generally mild in nature.
There is insufficient evidence to support the use of cinnamon for type 1 or type 2 diabetes mellitus. Further trials, which address the issues of allocation concealment and blinding, are now required. The inclusion of other important endpoints, such as health-related quality of life, diabetes complications and costs, is also needed.

1 Follower
 · 
140 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Schistosomiasis japonicum remains a considerable economic and public health concern in China, the Philippines and Indonesia. Currently available measures to control the unique intermediate host Oncomelania hupensis are frequently associated with severe side effects. Previous studies have demonstrated that linalool-rich extracts from various plants exhibited promising biological activities including cytotoxic, anti-microbial and anti-parasitic properties. Methods We identified the components of leaf extracts from Cinnamomum camphora by gas chromatography coupled to mass spectrometry (GC-MS) and investigated molluscicidal and larvicidal effects of linalool against O. hupensis and Schistosoma japonicium. The ultrastructural alterations in gills, salivary gland, stomach and hepatopancreas of snails were observed under the light microscope and transmission electron microscope, and lesions to tegument of cercaria were examined under a light microscope and fluorescence microscope. We then evaluated the effects of linalool on skin penetration and migration of schistosomula and adult survival by measurement of worm burden and egg counts in Balb/C mice infected with linalool-treated cercariae. Results In the present work, 44 components were identified from the leaf extracts of C. camphora, of which linalool was the most abundant constituent. Linalool exhibited the striking molluscicidal and larvicidal effects with LC50 = 0.25 mg/L for O. hupensis and LC50 = 0.07 mg/L for cercaria of S. japonicium. After exposure to linalool, damage to the gills and hepatopancreas of the snails, and to the tegument and body-tail joint of cercariae was apparent. In addition, linalool markedly reduced the recovered schistosomulum from mouse skin after challenge infection, and therefore decreased the worm burden in infected animals, but not fecundity of female adults of the parasite. Conclusions Our findings indicated that linalool might be a novel chemotherapeutic agent against S. japonicium and the snail intermediate host.
    Parasites & Vectors 08/2014; 7(1):407. DOI:10.1186/1756-3305-7-407 · 3.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Herbal medicine use is common in the United States, especially in immigrant populations. Understanding of this plant use is incomplete, with significant gaps in the literature for people living in the Midwest, about the plant species used, and about how home herbal medicine use interacts with allopathic medicine.
    WMJ: official publication of the State Medical Society of Wisconsin 04/2014; 113(2):64-71.
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the effect of cinnamon on menstrual cyclicity and metabolic dysfunction in women with Polycystic Ovary Syndrome STUDY DESIGN: In a prospective, placebo controlled, double-blinded randomized trial, 45 women with Polycystic Ovary Syndrome were randomized (1:1) to receive cinnamon supplements (1.5 grams/day) or placebo for 6 months. Menstrual cyclicity (average cycles/month) during the 6 months study period was compared between the two groups using the Mann-Whitney U test. Changes in menstrual cyclicity and insulin resistance between baseline and the 6 month study period were compared between the two groups using Wilcoxon signed rank tests. 45 women were randomized, 26 women completed 3 months of the study, and 17 women completed the entire 6 months of the study. During the 6 month intervention, menstrual cycles were more frequent in patients taking cinnamon compared to patients taking placebo (median (IQR) .75 (.5-.83) vs. .25 (0-.54), p=.0085, Mann Whitney U). In patients taking cinnamon, menstrual cyclicity improved from baseline (+ .23 cycles/month 95% CI, .099 - .36), yet did not improve for women taking placebo. (p=.0076, Wilcoxon signed rank) Samples (n=5) of serum from the luteal phase in different patients within the cinnamon group were thawed and ovulatory progesterone levels (> 3 ng/ml) confirmed. Luteal phase progesterone levels (>3 ng/ml, n=5) confirmed ovulatory menses. Measures of insulin resistance or serum androgen levels did not change for either group. These preliminary data suggest that cinnamon supplementation improves menstrual cyclicity and may be an effective treatment option for some women with Polycystic Ovary Syndrome.
    American journal of obstetrics and gynecology 05/2014; 211(5). DOI:10.1016/j.ajog.2014.05.009 · 3.97 Impact Factor

Full-text

Download
22 Downloads
Available from
Jul 21, 2014